THE RESULTS OF USE OF NEW NATIVE THROMBOLYTIC IN CLINICAL PRACTICE
Aim. To assess the efficacy of thrombolytic Fortelyzin in ST elevation myocardial infarction (STEMI) in real clinical practice.Material and methods. Fortelyzin was administered intravenously to 38 patients with STEMI with follow-up assessment of reperfusion success by ECG and angiographic criteria....
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2016-05-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/1229 |
| _version_ | 1797232223447941120 |
|---|---|
| author | E. S. Mazur R. M. Rabinovich V. V. Mazur N. S. Kuznetsova E. A. Kudryashova S. V. Veselov |
| author_facet | E. S. Mazur R. M. Rabinovich V. V. Mazur N. S. Kuznetsova E. A. Kudryashova S. V. Veselov |
| author_sort | E. S. Mazur |
| collection | DOAJ |
| description | Aim. To assess the efficacy of thrombolytic Fortelyzin in ST elevation myocardial infarction (STEMI) in real clinical practice.Material and methods. Fortelyzin was administered intravenously to 38 patients with STEMI with follow-up assessment of reperfusion success by ECG and angiographic criteria. Bleedings, anaphylaxis and total mortality were considered.Results. The ST-segment resolution up to 70% in 180 min was reached in 66% of patients and angiographic effect TIMI 2-3 – in 60% of patients. The major bleeding rate was 2.6%, allergic reactions – 0%, total mortality – 10.5%. Unsuccessful reperfusion was observed more frequently in patients with ECG ischemia of grade 3 and with angiographic visualization of the collateral blood flow.Conclusion. The general efficacy of Fortelyzin in real clinical practice was 73%. ECG ischemia of grade 3 and the presence of angiographic collateral blood flow predict unsuccessful reperfusion of the infarct-related artery. |
| first_indexed | 2024-03-08T14:02:58Z |
| format | Article |
| id | doaj.art-45c628cfcb8e4c56a893ba87d838c90d |
| institution | Directory Open Access Journal |
| issn | 1819-6446 2225-3653 |
| language | English |
| last_indexed | 2024-04-24T15:56:52Z |
| publishDate | 2016-05-01 |
| publisher | Столичная издательская компания |
| record_format | Article |
| series | Рациональная фармакотерапия в кардиологии |
| spelling | doaj.art-45c628cfcb8e4c56a893ba87d838c90d2024-04-01T07:43:33ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532016-05-0112216016510.20996/1819-6446-2016-12-2-160-1651199THE RESULTS OF USE OF NEW NATIVE THROMBOLYTIC IN CLINICAL PRACTICEE. S. Mazur0R. M. Rabinovich1V. V. Mazur2N. S. Kuznetsova3E. A. Kudryashova4S. V. Veselov5Tver State Medical University, TverRegional Clinic Hospital, TverTver State Medical University, TverTver State Medical University, TverRegional Clinic Hospital, TverTver State Medical University, TverAim. To assess the efficacy of thrombolytic Fortelyzin in ST elevation myocardial infarction (STEMI) in real clinical practice.Material and methods. Fortelyzin was administered intravenously to 38 patients with STEMI with follow-up assessment of reperfusion success by ECG and angiographic criteria. Bleedings, anaphylaxis and total mortality were considered.Results. The ST-segment resolution up to 70% in 180 min was reached in 66% of patients and angiographic effect TIMI 2-3 – in 60% of patients. The major bleeding rate was 2.6%, allergic reactions – 0%, total mortality – 10.5%. Unsuccessful reperfusion was observed more frequently in patients with ECG ischemia of grade 3 and with angiographic visualization of the collateral blood flow.Conclusion. The general efficacy of Fortelyzin in real clinical practice was 73%. ECG ischemia of grade 3 and the presence of angiographic collateral blood flow predict unsuccessful reperfusion of the infarct-related artery.https://www.rpcardio.online/jour/article/view/1229st elevation myocardial infarctionfibrinolysiscoronary blood flow |
| spellingShingle | E. S. Mazur R. M. Rabinovich V. V. Mazur N. S. Kuznetsova E. A. Kudryashova S. V. Veselov THE RESULTS OF USE OF NEW NATIVE THROMBOLYTIC IN CLINICAL PRACTICE Рациональная фармакотерапия в кардиологии st elevation myocardial infarction fibrinolysis coronary blood flow |
| title | THE RESULTS OF USE OF NEW NATIVE THROMBOLYTIC IN CLINICAL PRACTICE |
| title_full | THE RESULTS OF USE OF NEW NATIVE THROMBOLYTIC IN CLINICAL PRACTICE |
| title_fullStr | THE RESULTS OF USE OF NEW NATIVE THROMBOLYTIC IN CLINICAL PRACTICE |
| title_full_unstemmed | THE RESULTS OF USE OF NEW NATIVE THROMBOLYTIC IN CLINICAL PRACTICE |
| title_short | THE RESULTS OF USE OF NEW NATIVE THROMBOLYTIC IN CLINICAL PRACTICE |
| title_sort | results of use of new native thrombolytic in clinical practice |
| topic | st elevation myocardial infarction fibrinolysis coronary blood flow |
| url | https://www.rpcardio.online/jour/article/view/1229 |
| work_keys_str_mv | AT esmazur theresultsofuseofnewnativethrombolyticinclinicalpractice AT rmrabinovich theresultsofuseofnewnativethrombolyticinclinicalpractice AT vvmazur theresultsofuseofnewnativethrombolyticinclinicalpractice AT nskuznetsova theresultsofuseofnewnativethrombolyticinclinicalpractice AT eakudryashova theresultsofuseofnewnativethrombolyticinclinicalpractice AT svveselov theresultsofuseofnewnativethrombolyticinclinicalpractice AT esmazur resultsofuseofnewnativethrombolyticinclinicalpractice AT rmrabinovich resultsofuseofnewnativethrombolyticinclinicalpractice AT vvmazur resultsofuseofnewnativethrombolyticinclinicalpractice AT nskuznetsova resultsofuseofnewnativethrombolyticinclinicalpractice AT eakudryashova resultsofuseofnewnativethrombolyticinclinicalpractice AT svveselov resultsofuseofnewnativethrombolyticinclinicalpractice |